How much does a box of Upatinib cost in 2024?

Upadacitinib is an oral, selective Janus kinase 1 (JAK1) inhibitor, mainly used to treat moderately to severely active rheumatoid arthritis (< Immune-mediated inflammatory diseases such as /span>RA), atopic dermatitis (AD), psoriatic arthritis (PsA) and ankylosing spondylitis (AS). It reduces the release of pro-inflammatory cytokines by selectively inhibiting JAK1, thereby effectively reducing patients' inflammatory symptoms and joint damage and improving quality of life. Upadatinib provides a new treatment option for patients who have poor response or intolerance to traditional treatments.

Upadatinib is commonly available as an oral tablet, and recommended doses vary depending on the specific indication. For example, for patients with rheumatoid arthritis, the recommended dose is 15 mg once daily. When using upadatinib, patients need to regularly monitor blood routine, liver function, etc. to reduce the risk of adverse reactions. Common side effects include upper respiratory tract infection, headache, nausea and high blood lipids. In addition, upadatinib may also increase the risk of serious infections, thrombosis, and certain malignancies, so patients' underlying diseases and risk factors need to be carefully evaluated before use.

In terms of price, upadatinib is currently on the market in China and has been included in the scope of medical insurance. Patients can purchase the drug in regular domestic hospitals and pharmacies. After being included in medical insurance, the price of upadatinib is about 2,000 yuan. The specific price may vary slightly depending on the region. Patients can consult the local hospital pharmacy for detailed information and reimbursement ratio. Medical insurance coverage makes upadatinib more accessible to patients.

In addition, the price of foreign generic drugs of upadatinib is relatively low, especially the generic versions in Laos and Bangladesh, which cost around six to seven hundred yuan per box. Although they are cheap, the ingredients of these generic drugs are basically the same as those of domestic original drugs. However, when choosing a purchasing channel, patients need to ensure that the source of the drugs is formal and the safety and effectiveness of the drugs are guaranteed. These generic drugs provide an economic alternative for patients who want lower-cost access to treatment.